Form 4: Labcorp CLO gains shares via performance award

Labcorp’s EVP and Chief Legal Officer, Kathryn W. Kyle, acquired 1,584 shares from a vested performance award and had 451 shares withheld for taxes, resulting in a net increase of 1,133 shares.

Summary

• Reporting person: Kathryn W. Kyle, EVP and Chief Legal Officer of Labcorp Holdings Inc. (LH).
• Transaction date: 03/26/2026.
• Acquisition: 1,584 common shares at $0 (Code A) from a performance award.
• Withholding: 451 shares disposed (Code F) at $268.38 to satisfy tax withholding obligations.
• Net change in beneficial ownership: +1,133 shares.
• Post-transaction beneficial ownership: 4,575.4574 shares (direct).
• Performance award was granted on 02/07/2023 and related to the three-year performance period ending 12/31/2025.
• No 10b5-1(c) plan box indicated as checked.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as slightly positive due to a net increase in insider ownership from performance-based vesting with no discretionary selling.

Positives

• Net increase in insider ownership of 1,133 shares, indicating greater alignment with shareholders.
• Shares acquired via performance award vesting (1,584 shares), reflecting completion of the 2023–2025 performance period.
• No discretionary open-market sale; disposal was solely for tax withholding (451 shares at $268.38).

Future Outlook

NA

Management Comments

• Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
• Stock withholding to satisfy tax withholding obligations.

Industry Context

StockSavvy.ai notes that performance-based equity vesting with concurrent tax withholding is routine across healthcare services peers (e.g., Quest Diagnostics, IQVIA) and typically neutral for share prices unless accompanied by large discretionary insider sales.

Comparison to Industry Standards

• Consistent with large-cap healthcare services peers (Quest Diagnostics, IQVIA, Thermo Fisher) where executive performance shares vest post multi-year periods with automatic tax withholding.
• No discretionary open-market selling aligns with standard governance practices to avoid signaling concerns; many peers show similar Form 4 patterns around vesting dates.
• Net increase in insider ownership is generally viewed as slightly positive and in line with compensation frameworks at comparable companies.

Stakeholder Impact

• Executive’s increased share ownership (+1,133 net shares) may modestly strengthen alignment with shareholder interests.
• No direct operational or financial impact disclosed.

Key Dates

Keywords

Labcorp, LH, Form 4, insider transaction, performance award, executive compensation, stock withholding, beneficial ownership, Section 16, healthcare services